Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;49(4):270-8.
doi: 10.1007/s11626-013-9598-0. Epub 2013 Mar 22.

Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2

Affiliations

Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2

Xiao Yang et al. In Vitro Cell Dev Biol Anim. 2013 Apr.

Abstract

To evaluate the different traits of mesenchymal stem cell (MSC) isolated from osteosarcoma (OS) and normal bone marrow (BM) induced by bone-morphogenetic protein-2 (BMP-2). MSCs from implanted osteosarcoma or femur bone marrow were isolated and cultured. Differentiation potency was verified and phenotypes were evaluated by flow cytometry. Increased or decreased expressions of BMP-2 were delivered by adenovirus and lentivirus vector, respectively. Expressions of VEGF, EMMPRIN, and MMP-9 were examined. Cell cycle, apoptosis, invasiveness, and proliferation assays were performed between the transfected groups and controls. Increased BMP-2 induced over-expression of VEGF, EMMPRIN, and MMP-9 in OS- and BM-MSCs both intra- and extra-cellularly. Decreased BMP-2 expression induced inhibition of the factors. Increased BMP-2 also induced less population of cells at G1 phase, more apoptotic cells, more cells that invade through Transwell membrane, and faster proliferation in OSMSC compared to those in BMMSC. BMP-2 induced higher expression of tumorigenic factors, which could be responsible for promoting the proliferation and aggressiveness of OSMSC over BMMSC.

PubMed Disclaimer

References

    1. Histol Histopathol. 2003 Jul;18(3):981-7 - PubMed
    1. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12485-90 - PubMed
    1. J Cell Biochem. 1999 Mar 15;72(4):570-85 - PubMed
    1. J Clin Oncol. 2005 Feb 10;23(5):1011-27 - PubMed
    1. Br J Haematol. 1999 Nov;107(2):275-81 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources